VYNDAQEL
Analogs of VYNDAQEL
Find cheaper analogs and generic equivalents for VYNDAQEL.
Active Ingredient: TAFAMIDIS MEGLUMINE
Product Overview
About VYNDAQEL
VYNDAQEL is a medicine that contains the active ingredient TAFAMIDIS MEGLUMINE, used for the treatment of certain medical conditions. It is specifically designed to provide therapeutic benefits for patients with transthyretin-related hereditary amyloid polyneuropathy (hATTR-PN), a rare and debilitating condition. VYNDAQEL works by stabilizing the transthyretin protein, preventing its misfolding and aggregation, which can cause nerve damage and other symptoms associated with hATTR-PN.
Key Benefits & Uses
- Slows down the progression of nerve damage in patients with hATTR-PN
- Improves quality of life by reducing symptoms such as numbness, tingling, and muscle weakness
- Provides a convenient oral administration, making it easier for patients to manage their condition
Active Ingredient & Action
TAFAMIDIS MEGLUMINE, the active ingredient in VYNDAQEL, is a selective transthyretin stabilizer that works by binding to the transthyretin protein, preventing its dissociation into monomers and subsequent misfolding and aggregation. This mechanism of action helps to reduce the formation of amyloid deposits in the nerves and other tissues, thereby slowing down the progression of the disease.
Important Notes
Patients should take VYNDAQEL exactly as prescribed by their doctor, and it is essential to follow the recommended dosage and administration instructions. It is also crucial to discuss any potential side effects, allergies, or interactions with other medications with a healthcare professional before starting treatment with VYNDAQEL.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.